{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [{"AbstractText": ["Topinambur (Helianthus tuberosus L.), zwany r\u00f3wnie\u017c s\u0142onecznikiem bulwiastym, jest ro\u015blin\u0105 pochodz\u0105c\u0105 z Ameryki P\u00f3\u0142nocnej, sk\u0105d przywieziony zosta\u0142 do Europy w XVII w. Od wiek\u00f3w hodowany by\u0142 dla jadalnych bulw i ze wzgl\u0119du na swoje w\u0142a\u015bciwo\u015bci lecznicze.Celem artyku\u0142u jest przedstawienie w\u0142a\u015bciwo\u015bci medycznych oraz zastosowania topinamburu w diecie pacjenta. Na zwierz\u0119tach przeprowadzono wiele bada\u0144, maj\u0105cych na celu okre\u015blenie medycznych w\u0142a\u015bciwo\u015bci topinamburu. W ten spos\u00f3b wykazano, \u017ce topinambur ma w\u0142a\u015bciwo\u015bci obni\u017caj\u0105ce poziom glukozy, cholesterolu ca\u0142kowitego oraz trigliceryd\u00f3w w osoczu. Uwa\u017ca si\u0119, \u017ce za te efekty odpowiada du\u017ca ilo\u015b\u0107 inuliny, zawarta w bulwach. Dzia\u0142anie inuliny na organizm ludzki zosta\u0142o oceniane w wielu badaniach klinicznych. Uwa\u017ca si\u0119, \u017ce inulina ma w\u0142a\u015bciwo\u015bci prebiotyczne, obni\u017caj\u0105c st\u0119\u017cenie glukozy we krwi oraz powoduj\u0105c spadek pH w jelicie, co zwi\u0119ksza biodost\u0119pno\u015b\u0107 wapnia. Dodatkowo ma pozytywny wp\u0142yw na profil lipidowy osocza oraz dzia\u0142a immunomoduluj\u0105co przez wp\u0142yw na tkank\u0119 limfatyczn\u0105 przewodu pokarmowego. W zwi\u0105zku ze swoimi w\u0142a\u015bciwo\u015bciami mo\u017ce by\u0107 wykorzystana w diecie os\u00f3b choruj\u0105cych na cukrzyc\u0119 typu 2 oraz oty\u0142ych. W ostatnich latach odkryto r\u00f3wnie\u017c kolejne zastosowanie topinamburu. Okaza\u0142o si\u0119, \u017ce wydzielina z jego bulwy dzia\u0142a cytotoksycznie wobec kom\u00f3rek raka sutka."], "CopyrightInformation": "\u00a9 Polish Society for Pediatric Endocrinology and Diabetology."}], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29073305", "DateCompleted": {"Year": "2018", "Month": "06", "Day": "19"}, "DateRevised": {"Year": "2018", "Month": "06", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["pol"], "ELocationID": ["10.18544/PEDM-23.01.0071"], "Journal": {"ISSN": "2083-8441", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2017"}}, "Title": "Pediatric endocrinology, diabetes, and metabolism", "ISOAbbreviation": "Pediatr Endocrinol Diabetes Metab"}, "ArticleTitle": "[Topinambour - nutritional and medical properties of the Jerusalem artichoke (Helianthus tuberoses L.)].", "Pagination": {"StartPage": "30", "EndPage": "36", "MedlinePgn": "30-36"}, "Abstract": {"AbstractText": ["Topinambour (Helianthus tuberosus L.), also known as the Jerusalem artichoke is a plant, which origins from North America. In XVII century it was brought to the Europe. For ages it was cultivated due to edible tuber and its healing properties.The aim of the article is to present medical properties and application of topinmbour in patient's diet. Many studies were performed on animals to specify medical properties of topinambour. Results show, that topinambour lowers plasma glucose, total cholesterol and triglyceride levels. It is believed that these effects are caused by high level of inulin present it its tuber.Inulin effect on the human organism was assessed in many clinical studies. It is thought it has prebiotic features, lowers plasma glucose and intestinal pH level, which results in higher calcium bioavailability. Additionaly, it has a positive impact on the plasma lipid profile, acts as an immunomodulator, affecting digestive systems' limfatic tissue. Due to its characteristics, it can be used in the diet of obese and type 2 diabetes mellitus patients.Recently, it was discovered that topinambour tuber secretion works as a cytotoxic agent contra breast cancer cells."], "CopyrightInformation": "\u00a9 Polish Society for Pediatric Endocrinology and Diabetology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Faculty, Wroclaw Medical University."}], "LastName": "Horochowska", "ForeName": "Michalina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Faculty, Wroclaw Medical University."}], "LastName": "Ko\u0142eczek", "ForeName": "El\u017cbieta", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department and Clinic of Endocrinology, Diabetology and Isotope Therapy, Wroclaw Medical University."}], "LastName": "Zdrojewicz", "ForeName": "Zygmunt", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Faculty, Wroclaw Medical University."}], "LastName": "Jagie\u0142\u0142o", "ForeName": "Jacek", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Faculty, Wroclaw Medical University."}], "LastName": "Pawlus", "ForeName": "Karolina", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Review"], "VernacularTitle": "Topinambur \u2013 w\u0142a\u015bciwo\u015bci od\u017cywcze i lecznicze s\u0142onecznika bulwiastego (Helianthus tuberosus L.)."}, "MedlineJournalInfo": {"Country": "Poland", "MedlineTA": "Pediatr Endocrinol Diabetes Metab", "NlmUniqueID": "101518750", "ISSNLinking": "2083-8441"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Prebiotics"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Europe"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry"], "DescriptorName": "Helianthus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Tubers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prebiotics"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "10", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "21", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29073305", "10.18544/PEDM-23.01.0071"]}}]}